Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Covers preparation, sterile technique, concentration calculations, and proper storage at 2-8C
Precision Synthetics Canada puts additional emphasis on documentation, identity review, and LAL endotoxin screening where supported because research peptide listings can otherwise stop at HPLC purity alone
Ondo, W
Patients who should not receive BPC-157 include: those with active or recent malignancies (due to angiogenic concerns), pregnant or breastfeeding women (no reproductive toxicology data in humans), patients on anticoagulation therapy (theoretical bleeding risk from angiogenesis at ulcer sites), and minors (no pediatric data of any kind)
/media/img/mt/2026/07/PeptideGoldRush/original.png){kind=icon}
